{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:21:04Z","timestamp":1787026864893,"version":"build-2736575974"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Spinal Muscular Atrophy (SMA) is an inherited neuromuscular disorder characterized by progressive muscle weakness and atrophy, resulting from the degeneration of motor neurons in the spinal cord. A critical aspect of SMA is its impact on respiratory function. As the disease progresses, respiratory muscles, in particular intercostal muscles, become increasingly affected, leading to breathing difficulties and respiratory failure. Without intervention, many children with SMA type 1 die from respiratory failure before their second year of life. While assisted ventilation has improved survival, it often results in ventilator dependence. The development of new SMN-augmenting therapies has renewed optimism, but their long-term impact on respiratory function is uncertain, and non-invasive respiratory support remains an important part of SMA management. Despite the importance of respiratory support in SMA, knowledge regarding sleep disorders in this population is limited. This review aims to synthesize existing literature on sleep and sleep-related breathing disorders in patients with SMA, with a focus on SMA type 1. We summarize evidence of sleep-disordered breathing and respiratory failure in SMA, as well as outcomes and survival benefits associated with non-invasive or invasive ventilation with or without pharmacological therapies. We also discuss current knowledge regarding the effects of novel disease-modifying therapies for SMA on respiratory function and sleep. In conclusion, optimal care for children with SMA requires a multidisciplinary approach that includes neurology and respiratory specialists. This review highlights the importance of monitoring sleep and respiratory function in SMA, as well as the potential benefits and challenges associated with assisted ventilation combined with new therapies.<\/jats:p>","DOI":"10.3389\/fneur.2024.1299205","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T01:48:29Z","timestamp":1717465709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?"],"prefix":"10.3389","volume":"15","author":[{"given":"Elena","family":"Abati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rimoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Madini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Patria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D\u2019Amico","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","article-title":"Spinal muscular atrophy: in the challenge lies a solution","volume":"44","author":"Wirth","year":"2021","journal-title":"Trends Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","article-title":"Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next","volume":"21","author":"Wirth","year":"2020","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1093\/hmg\/ddq425","article-title":"A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2","volume":"19","author":"Jodelka","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","article-title":"An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN","volume":"9","author":"Lorson","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","article-title":"Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy","volume":"8","author":"Mitrpant","year":"2013","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1090-3798(99)80012-9","article-title":"Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype","volume":"3","author":"Dubowitz","year":"1999","journal-title":"Eur J Paediatr Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","article-title":"Spinal muscular atrophy: mutations, testing, and clinical relevance","volume":"14","author":"Keinath","year":"2021","journal-title":"Appl Clin Genet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/s0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"Munstat","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in treatment of spinal muscular atrophy \u2013 new phenotypes, new challenges, new implications for care","volume":"7","author":"Schorling","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/s0140-6736(95)91835-3","article-title":"Genetic basis of adult-onset spinal muscular atrophy","volume":"346","author":"Zerres","year":"1995","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"","journal-title":"Neuromuscul Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7S45","DOI":"10.1016\/S0929-693X(20)30277-3","article-title":"Multidisciplinary approach and psychosocial Management of Spinal Muscular Atrophy (SMA)","volume":"27","author":"Ropars","year":"2020","journal-title":"Arch Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.nmd.2004.09.004","article-title":"Sleep disordered breathing in spinal muscular atrophy","volume":"14","author":"Mellies","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejpn.2013.04.004","article-title":"Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3","volume":"17","author":"Khirani","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-022-02227-7","article-title":"Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study","volume":"17","author":"Veldhoen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/0883073818818169","article-title":"Normal reference values for peak expiratory flow in children and adolescents with spinal muscular atrophy","volume":"34","author":"Wijngaarde","year":"2019","journal-title":"J Child Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"NatHis-SMA study group. Natural history of type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.sleep.2021.11.006","article-title":"Sleep breathing disorders in pediatric patients with spinal muscular atrophy 2","volume":"89","author":"Bertr\u00e1n","year":"2022","journal-title":"Sleep Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ppul.22997","article-title":"Respiratory muscle function in infants with spinal muscular atrophy type I","volume":"49","author":"Finkel","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1002\/ppul.26133","article-title":"Respiratory muscle fatigability in patients with spinal muscular atrophy","volume":"57","author":"Kant-Smits","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1212\/WNL.0000000000011051","article-title":"Respiratory trajectories in type 2 and 3 spinal muscular atrophy in the iSMAC cohort study","volume":"96","author":"Trucco","year":"2021","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-023-02634-4","article-title":"Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study","volume":"18","author":"Veldhoen","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nmd.2003.09.003","article-title":"117th ENMC workshop: ventilatory support in congenital neuromuscular disorders -- congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4\u20136 April 2003, Naarden, the Netherlands","volume":"14","author":"Wallgren-Pettersson","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0165818","DOI":"10.1371\/journal.pone.0165818","article-title":"Spontaneous breathing pattern as a respiratory functional outcome in children with spinal muscular atrophy (SMA)","volume":"11","author":"LoMauro","year":"2016","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/mus.27404","article-title":"Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation","volume":"64","author":"Wolfe","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.nmd.2015.09.009","article-title":"Casiraghi JL; Italian SMA family association. 1st Italian SMA family association consensus meeting: management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30\u201331 January 2015","volume":"25","author":"Sansone","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"7S29","DOI":"10.1016\/S0929-693X(20)30274-8","article-title":"Respiratory management of children with spinal muscular atrophy (SMA)","volume":"27","author":"Fauroux","year":"2020","journal-title":"Arch Pediatr"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.sleep.2019.12.004","article-title":"Polysomnography findings in pediatric spinal muscular atrophy types 1-3","volume":"68","author":"Chacko","year":"2020","journal-title":"Sleep Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.chest.2017.03.023","article-title":"Sleep-disordered breathing in neuromuscular disease: diagnostic and therapeutic challenges","volume":"152","author":"Aboussouan","year":"2017","journal-title":"Chest"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1440-1754.2005.00691.x","article-title":"Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population","volume":"41","author":"Suresh","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1203\/PDR.0b013e318179951d","article-title":"Relationship between functional residual capacity and oxygen desaturation during short central apneic events","volume":"64","author":"Tourneux","year":"2008","journal-title":"Pediatr Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.prrv.2018.07.006","article-title":"The role of sleep diagnostics and non-invasive ventilation in children with spinal muscular atrophy","volume":"28","author":"Grychtol","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.nmd.2020.09.001","article-title":"The effects of non-invasive mechanical ventilation on cardiac autonomic dysfunction in spinal muscular atrophy","volume":"30","author":"Senel","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/09031936.00050708","article-title":"Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease","volume":"33","author":"Fauroux","year":"2009","journal-title":"Eur Respir J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1590\/S0004-282X1994000400004","article-title":"Sleep polygraphic parameters in neuromuscular diseases","volume":"52","author":"Pradella","year":"1994","journal-title":"Arq Neuropsiquiatr"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/01.phm.0000176362.24957.77","article-title":"Sleep-disordered breathing in spinal muscular atrophy types 1 and 2","volume":"84","author":"Testa","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.sleep.2014.05.029","article-title":"Sleep architecture in infants with spinal muscular atrophy type 1","volume":"15","author":"Verrillo","year":"2014","journal-title":"Sleep Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2015.12.015","article-title":"Sleep architecture in children with spinal muscular atrophy type 2","volume":"20","author":"Verrillo","year":"2016","journal-title":"Sleep Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/thorax-2022-219582","article-title":"British Thoracic Society guideline for diagnosing and monitoring paediatric sleep-disordered breathing","volume":"78","author":"Evans","year":"2023","journal-title":"Thorax"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-444-64032-1.00025-4","article-title":"Polysomnography","volume":"160","author":"Rundo","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jcrc.2016.04.003","article-title":"Sleep study as a diagnostic tool for unexplained respiratory failure in infants hospitalized in the PICU","volume":"42","author":"Griffon","year":"2017","journal-title":"J Crit Care"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5665\/sleep.1710","article-title":"AASM criteria for scoring respiratory events: interaction between apnea sensor and hypopnea definition","volume":"35","author":"Thornton","year":"2012","journal-title":"Sleep"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S2213-2600(16)30151-5","article-title":"Long-term non-invasive ventilation in children","volume":"4","author":"Amaddeo","year":"2016","journal-title":"Lancet Respir Med"},{"key":"ref50","volume-title":"The AASM manual for the scoring of sleep an associated events: Rules, terminology and technical specifications. Version 2.5","author":"Berry","year":"2018"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11325-014-0980-2","article-title":"Carbon dioxide levels during polygraphy in children with sleep-disordered breathing","volume":"19","author":"Pautrat","year":"2015","journal-title":"Sleep Breath"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/ppul.24455","article-title":"Relationship between respiratory function and need for NIV in childhood SMA","volume":"54","author":"Kapur","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"S29.003","DOI":"10.1212\/WNL.90.15_supplement.S29.003","article-title":"AVXS-101 phase 1 gene replacement therapy clinical trial in SMA type 1: continued Independence from nutritional and Ventilatory support in patients dosed early in disease progression","volume":"90","author":"Shell","year":"2018","journal-title":"Neurology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/01.PHM.0000083669.22483.04","article-title":"Prevention of pectus excavatum for children with spinal muscular atrophy type 1","volume":"82","author":"Bach","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/adc.2009.177832","article-title":"Outcome of goal-directed non-invasive ventilation and mechanical insufflation\/exsufflation in spinal muscular atrophy type I","volume":"96","author":"Chatwin","year":"2011","journal-title":"Arch Dis Child"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"4701736","DOI":"10.1155\/2018\/4701736","article-title":"Use of noninvasive ventilation with volume-assured pressure support to avoid tracheostomy in severe obstructive sleep apnea","volume":"2018","author":"Diaz-Abad","year":"2018","journal-title":"Case Rep Pediatr"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/rcr2.117","article-title":"Nocturnal respiratory failure in a child with congenital myopathy \u2013 management using average volume-assured pressure support (AVAPS)","volume":"3","author":"Gentin","year":"2015","journal-title":"Respirol Case Rep"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/ppul.26492","article-title":"Why home NIV devices should have a Ti min\/Ti max?","volume":"58","author":"Khirani","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1378\/chest.116.2.521","article-title":"Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report","volume":"116","author":"Goldberg","year":"1999","journal-title":"Chest"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1183\/09031936.00144807","article-title":"Performance of ventilators for noninvasive positive-pressure ventilation in children","volume":"31","author":"Fauroux","year":"2008","journal-title":"Eur Respir J"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ppul.10110","article-title":"Spinal muscular atrophy type 1: management and outcomes","volume":"34","author":"Bach","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00134-012-2806-7","article-title":"Polygraphic respiratory events during sleep with noninvasive ventilation in children: description, prevalence, and clinical consequences","volume":"39","author":"Caldarelli","year":"2013","journal-title":"Intensive Care Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/ppul.24942","article-title":"Built-in software in children on long-term ventilation in real life practice","volume":"55","author":"Onofri","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neurol.2012.07.020","article-title":"Recommendations for the diagnosis and management of typical childhood spinal muscular atrophy","volume":"168","author":"Cuisset","year":"2012","journal-title":"Rev Neurol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1378\/chest.126.3.831","article-title":"Respiratory capacity course in patients with infantile spinal muscular atrophy","volume":"126","author":"Ioos","year":"2004","journal-title":"Chest"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/PHM.0b013e31804a8505","article-title":"Long-term survival in Werdnig-Hoffmann disease","volume":"86","author":"Bach","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/pai.2009.0002","article-title":"Spinal muscular atrophy type 1: prolongation of survival by noninvasive respiratory aids","volume":"22","author":"Bach","year":"2009","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2101404","DOI":"10.1183\/13993003.01404-2021","article-title":"ERS statement on paediatric long-term noninvasive respiratory support","volume":"59","author":"Fauroux","year":"2022","journal-title":"Eur Respir J"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e1509","DOI":"10.1542\/peds.2012-2278","article-title":"Survival of patients with spinal muscular atrophy type 1","volume":"131","author":"Gregoretti","year":"2013","journal-title":"Pediatrics"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ppul.21617","article-title":"International survey of physician recommendation for tracheostomy for spinal muscular atrophy type I","volume":"47","author":"Benson","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","article-title":"Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: a systematic review of real-world study data","volume":"39","author":"Erdos","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/brain\/awac252","article-title":"SMArtCARE study group. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy","volume":"146","author":"Pechmann","year":"2023","journal-title":"Brain"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ppul.26173","article-title":"Respiratory characteristics in children with spinal muscular atrophy type 1 receiving nusinersen","volume":"58","author":"Xiao","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/children9081207","article-title":"Changes in Ventilatory support requirements of spinal muscular atrophy (SMA) patients post gene-based therapies","volume":"9","author":"Panagiotou","year":"2022","journal-title":"Children (Basel)"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejpn.2021.02.007","article-title":"Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy \u2013 a single-center retrospective study","volume":"31","author":"Heitschmidt","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1212\/WNL.0000000000006281","article-title":"Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: a cohort study","volume":"91","author":"Aragon-Gawinska","year":"2018","journal-title":"Neurology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ppul.25140","article-title":"Nusinersen for spinal muscular atrophy type 1: real-world respiratory experience","volume":"56","author":"Lavie","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JND-180315","article-title":"Evaluation of children with SMA type 1 under treatment with Nusinersen within the expanded access program in Germany","volume":"5","author":"Pechmann","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.arcped.2023.10.009","article-title":"Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type","volume":"31","author":"Audic","year":"2024","journal-title":"Arch Pediatr"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpeds.2019.12.047","article-title":"Respiratory needs in patients with type 1 spinal muscular atrophy treated with Nusinersen","volume":"219","author":"Sansone","year":"2020","journal-title":"J Pediatr"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e15310","DOI":"10.1111\/ped.15310","article-title":"The effects of nusinersen treatment on respiratory status of children with spinal muscular atrophy","volume":"64","author":"Hepkaya","year":"2022","journal-title":"Pediatr Int"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.ejpn.2017.04.1218","article-title":"Efficacy and safety of nusinersen in infants with presymptomatic spinal muscular atrophy (SMA): interim results from the NURTURE study","volume":"21","author":"Bertini","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.nmd.2023.04.007","article-title":"Respiratory and sleep outcomes in children with SMA treated with nusinersen \u2013 real world experience","volume":"33","author":"Gonski","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12519-022-00638-x","article-title":"Nusinersen for spinal muscular atrophy types II and III: a retrospective single-center study in South Korea","volume":"19","author":"Shin","year":"2023","journal-title":"World J Pediatr"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ppul.25142","article-title":"Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen","volume":"56","author":"G\u00f3mez-Garc\u00eda de la Banda","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/thoraxjnl-2020-216564","article-title":"Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1\u20133","volume":"77","author":"Chacko","year":"2022","journal-title":"Thorax"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.sleep.2023.07.024","article-title":"Sleep architecture and Nusinersen therapy in children with spinal muscular atrophy type 1","volume":"110","author":"Verrillo","year":"2023","journal-title":"Sleep Med"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","article-title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"101997","DOI":"10.1016\/j.eclinm.2023.101997","article-title":"Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na\u00efve patients with spinal muscular atrophy and following switch from other therapies","volume":"59","author":"Pane","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/ppul.26285","article-title":"A breakthrough effect of gene replacement therapy on respiratory outcomes in children with spinal muscular atrophy","volume":"58","author":"AlNaimi","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaneurol.2021.1272","article-title":"Five-year extension results of the phase 1 START trial of Onasemnogene Abeparvovec in spinal muscular atrophy","volume":"78","author":"Mendell","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/acn3.51519","article-title":"Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy","volume":"9","author":"D\u2019Silva","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ppul.24203","article-title":"Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy","volume":"54","author":"Al-Zaidy","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.sleep.2022.11.006","article-title":"Polysomnography findings in children with spinal muscular atrophy after onasemnogene-abeparvovec","volume":"101","author":"Leon-Astudillo","year":"2023","journal-title":"Sleep Med"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2102047","article-title":"Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls","volume":"385","author":"Darras","year":"2021","journal-title":"N Engl J Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N Engl J Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/phar.2866","article-title":"Efficacy of risdiplam in spinal muscular atrophy: a systematic review and meta-analysis","volume":"44","author":"Pascual-Morena","year":"2023","journal-title":"Pharmacotherapy"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1299205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T06:14:34Z","timestamp":1721369674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1299205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":101,"alternative-id":["10.3389\/fneur.2024.1299205"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1299205","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"article-number":"1299205"}}